Al-Wakeel Yasir B. 4
4 · Kronos Bio, Inc. · Filed Jul 27, 2022
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Al-Wakeel Yasir B.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-07-25+40,000→ 40,000 totalExercise: $5.02Exp: 2032-07-24→ Common Stock (40,000 underlying) - Award
Common Stock
2022-07-25+53,600→ 216,841 total
Footnotes (1)
- [F1]50% of the shares subject to the stock option shall vest and become exercisable on June 30, 2023 and the remaining shares shall vest and become exercisable on December 31, 2023.